NCT06202690
SP Robotic Versus VATS Anatomical Pulmonary Resection for Patients With NSCLC
Not Yet Recruiting · Not Applicable · Korea University Guro Hospital · registry updated 2024-01-11
Inclusion and exclusion lines below are quoted from ClinicalTrials.gov. No match score is shown, because a score needs a person's age, biomarkers, and treatment dates. Confirm the record with the study team.
Single-POrt Robotic-assisted thoracic surgery versus single-port video-assisted Thoracic Surgery major pulmonary resection for patients with non-small cell lung cancer (SPORTS trial): a single-center, a single blinded, randomized controlled trial
Inclusion
- Candidate for anatomical pulmonary resection (segmentectomy or lobectomy) via minimally invasive thoracic surgery (RATS or VATS) for patient with non-small cell lung cancer or suspected malignant lesion.
- Age ≥ 18 years
- Patients who can comply with the requirements of the clinical trial and who, or their legal representatives, provide written consent before the start of the clinical trial
- Patients with the nationality of South Korea
- American Society of Anesthesiologists score 1-3.
- Clinical stage I, II or IIIa non-small cell lung cancer (NSCLC)
Exclusion
- Patients who require surgery for accompanying other organ diseases
- Tumor invasion into the chest wall, diaphragm, another lobe or diaphragm
- Patients who are considered unsuitable based on the researcher's judgment
- Patients with cognitive impairments who are unable to understand the instructions and informed consent of this study
- Patients who specifically desire a certain surgical method (robotic, thoracoscopic, open thoracotomy)
- Patients who previously undergone a thoracic surgical procedure in the hemithorax to be operated on